The research-driven business BioRadius Therapeutic Research was established in 2018 by two distinguished researchers who believed that "Quality Generics is a must, not an option." Over 130 studies have been successfully finished by BioRadius since its founding, and it has submitted research to numerous international regulatory bodies, including the USFDA and EMA.
In order to help pharmaceutical, biotech, and medical device firms save costs, increase income, and expand their market reach, BioRadius provides them with support for clinical trials, bioequivalence studies, bioanalytical services, monitoring, and product characterization. In order to help our clients expedite the clinical trial lifecycle and effectively navigate regulatory compliance pathways, we align our services without sacrificing quality.